Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

WHO Recommends Adding Swine Flu to Regular Vaccine

By Drug Discovery Trends Editor | February 22, 2010

LONDON (AP) – The World Health Organization is recommending that swine flu be added to regular flu vaccines next season.

The swine flu pandemic virus, or H1N1, emerged too late last year to be added to the regular flu vaccine, and a separate vaccine was needed.

For this year’s northern hemisphere flu season, however, the two vaccines should be combined, WHO flu chief Keiji Fukuda said Thursday after the agency met this week to decide which strains should be recommended to drug makers for vaccines.

But including protection against swine flu in the usual vaccine doesn’t mean the pandemic has ended. The WHO expects swine flu will remain a significant threat.

“The recommendation to put the (swine flu) virus into the vaccine for the fall and winter is really a separate issue from whether the pandemic is over,” Fukuda said.

Other experts agreed. “I wouldn’t write the obituary for H1N1 just yet,” said Michael Osterholm, a flu expert at the University of Minnesota. He said pandemic viruses in the past have caused waves of disease up to three years after the first outbreak.

Flu vaccines usually have three virus strains – which experts decide on after estimating which strains made the most people sick last season. Pharmaceutical companies and national authorities decide whether all three strains should go into the same vaccine or whether they should be split into different vaccines.

In September, the WHO recommended the swine flu vaccine be included in the southern hemisphere’s next flu vaccine.

The WHO will hold a meeting of experts Tuesday to discuss whether the pandemic has peaked, Fukuda said. Such an announcement, however, would have little practical effect; countries like the U.S. and Britain have already scaled back their swine flu response and cases have dropped sharply.

Osterholm said flu experts simply haven’t figured out how to define when a pandemic ends.

“If H1N1 comes back in a couple of months, is it a wave or is it just normal flu?” he asked. “There’s no scoreboard for us to check that.”

More than 15,000 people have died after being diagnosed with swine flu since it first broke out in April, though the true number is likely higher as most countries aren’t counting individual cases. Most people who catch the virus only experience mild symptoms and don’t need treatment.

Date: February 18, 2010
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
Drug companies sign “Most Favored Nation” deals, then raise prices anyway
New gonorrhea antibiotic could treat resistant infections
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE